Research funder · United States
Muscular Dystrophy Association
American organization which combats muscular dystrophy
- Grants since 2016
- 438
- Awarded, last 5 years (where amounts are published)
- $37.7M + 1.5M
- Funded works, last 5 years
- 1 011
- Funded works, all time
- 9 236
Grants
2024–2027 · research · Development Grant
Notch Pathway modulation in Satellite Cells of two novel mdx models
Felipe De Souza Leite · Boston Children's Hospital
2024–2027 · research · Development Grant
Addressing Immunotoxicities to AAV Gene Therapy for DMD and Other Disorders
Bradley Hamilton · Stanford University
2024–2027 · research · Infrastructure Grant
A Comprehensive Database for RYR1-Related Disorders
Joshua Todd · National Institute of Neurological Disorders and Stroke
2024–2027 · research · Development Grant
Aberrant mt-mRNA folding as mediator of mitochondrial encephalomyopaties
Michele Brischigliaro · University of Miami
2024–2025 · research · Restricted Research Grant
New Pathways of Protein Homeostasis in ALS
Jeffrey Rothstein · Johns Hopkins University
2024–2027 · research · Research Grant
Early neuromesodermal defects underlie SMA pathology
Natalia Rodriguez-Muela · German Center for Neurodegenerative Diseases
2024 · research · Restricted Research Grant
Remote assessments for Myotonic Dystrophy
Johanna Hamel · University of Rochester
2024–2027 · research · Clinical Research Grant
HEALEY ALS Platform Trial
Sabrina Paganoni · Massachusetts General Hospital
2024–2025 · research · Restricted Research Grant
Clinical Research in ALS (CRiALS)
Jonathan Glass · Emory University
2024–2027 · research · Research Grant
Novel approaches for understanding and preventing AAV non-muscle toxicity
James Dowling · Hospital for Sick Children
2024–2027 · research · Research Grant
High-fidelity dual RNA-targeting CRISPR systems for the C9ORF72 repeat RNAs
Thomas Gaj · University of Illinois Urbana-Champaign
2024–2027 · research · Development Grant
Development of next-generation therapies for Duchenne muscular dystrophy
Hichem Tasfaout · University of Washington
2024–2027 · award
Therapeutic effects of Antisense Oligonucleotide for Treatment of VCP Disease
Virginia Kimonis · University of California, Irvine
2024–2027 · research · Research Grant
microRNA as biomarkers for phenoconversion in pre familial ALS
Eran Hornstein · Weizmann Institute of Science
2024–2027 · research · Research Grant
Single-cell Multiomic analysis of cellular and epigenetic dynamics in EDMD
Lorenzo Giordani · Inserm
2024–2027 · research · Research Grant
Prime editing system for the in vivo correction of muscular dystrophy mutations
Scot Wolfe · University of Massachusetts Chan Medical School
2024–2027 · research · Development Grant
Investigating mechanistic drivers of MuSK autoimmunity
Gianvito Masi · Yale University
2024–2027 · research · Research Grant
Targeting overexpressed transcription co-regulators to suppress SBMA
Maria Pennuto · University of Padua
2024–2027 · research · Development Grant
Defining the Protective Effects of Estrogen in FSHD
Adam Bittel · Children's Research Institute (cnmc)
2024–2027 · research · Research Grant
Stem Cell Targeting in Duchenne Muscular Dystrophy
April Pyle · The Regents Of The University Of California, Los Angeles
2023–2024 · research · Restricted Research Grant
Clinical Research in ALS (CRiALS): A comprehensive resource for human research
Jonathan Glass · Emory University
2023–2024 · research · Restricted Research Grant
Mini-dystrophin function in the cxmd model
Jeffrey Chamberlain · University of Washington
2023–2026 · research · Research Grant
The molecular basis of muscular dystrophy caused by loss of MSTO1 function
Suzanne Hoppins · University of Washington
2023–2026 · research · Research Grant
Aberrant mitochondrial mRNA folding as mediator of Leigh's syndrome
Antoni Barrientos · University of Miami
2023–2026 · research · Development Grant
Extracellular vesicle metabolome in Myotonic dystrophy 1
Preeti Kumari · Massachusetts General Hospital
2023–2026 · research · Research Grant
Seizure susceptibility in congenital muscular dystrophies
Kevin Wright · Oregon Health & Science University
2023–2026 · research · Development Grant
Investigation of ALS caused by mutant KIF5A
Devesh Pant · Emory University
2023–2026 · research · Research Grant
Mechanisms of fatty liver disease and impaired drug metabolism in DM1
Auinash Kalsotra · University of Illinois Urbana-Champaign
2023–2026 · research · Research Grant
Disrupted nuclear pore complex surveillance as an initiating event in ALS
Alyssa Coyne · Johns Hopkins University
2023–2026 · research · Development Grant
Targeting layered regenerative inflammation tissue zones in dystrophic muscle
Andreas Patsalos · Johns Hopkins University
2023–2026 · research · Research Grant
A novel RNA treatment for Amyotrophic lateral sclerosis (ALS)
Eran Perlson · Tel Aviv University
2023–2026 · research · Research Grant
Mechanisms and treatment of muscle pathology in spinal muscular atrophy
Umrao Monani · Columbia University Irving Medical Center
2023–2026 · research · Research Grant
Understanding how VCP mutations cause Amyotrophic Lateral Sclerosis
Malavika Raman · Tufts University
2023–2026 · research · Research Grant
Metabolic therapies for dystrophic cardiomyopathy
Daniel Michele · Regent University
2023–2026 · research · Development Grant
Defining Cell and non-cell autonomous contribution of STING signaling in ALS
Christine Marques · Massachusetts General Hospital
2023–2026 · research · Research Grant
Overexpression of CD82 to improve dystrophic myofiber stability
Emanuela Gussoni · Boston Children's Hospital
2023–2025 · research · Research Grant
Quantifying Gait Velocity with the ActiMyo Wearable Devices in ALS
James Berry · Massachusetts General Hospital
2023–2026 · research · Research Grant
Astrocyte-microglia crosstalk in C9orf72 ALS/FTD
Rita Sattler · St. Joseph's Hospital and Medical Center
2023–2026 · research · Research Grant
Preclinical Assessment of Gene Editing Efficacy in Periodic Paralysis
Steve Cannon · The Regents Of The University Of California, Los Angeles
2023–2026 · research · Development Grant
Unraveling the contribution of local translation to NMJ degeneration in FUS-ALS
Diana Piol · Vlaams Instituut voor Biotechnologie